Valuation: Ainos, Inc.

Market Cap 10.93M 9.53M 9M 8.17M 15.31M 1.05B 15.37M 108M 41.59M 533M 41.05M 40.14M 1.72B P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 21.51M 18.76M 17.71M 16.08M 30.13M 2.06B 30.26M 212M 81.87M 1.05B 80.81M 79.01M 3.38B EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
24.76%
Yield 2024 *
-
Yield 2025 -
1 day-0.67%
1 week+2.78%
Current month+5.71%
3 months-19.13%
6 months+2.07%
Current year-9.76%
1 week 1.34
Extreme 1.34
1.5
1 month 1.34
Extreme 1.34
1.67
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.44
3 years 1.26
Extreme 1.26
21.45
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap. Importance
6/3/26 A Buy

Director

2,000 0.0286%
5/28/26 A Buy

Director

250 0.0036%
5/27/26 A Buy

Director

2,000 0.0286%
Change 5-day change 1-year change 3-year change Capi.($)
-0.67%+2.78%-60.64%-91.42% 10.93M
-1.04%+6.83%+35.84%+28.05% 241B
-0.32%+5.83%+9.58%-17.01% 149B
+2.55%+6.55%-10.35%+31.26% 139B
-0.48%+0.84%-55.70%-18.27% 62.81B
+0.01%+4.61%+18.61%+20.87% 50.87B
-1.69%-1.20%-19.89%-15.39% 48.21B
+0.08%+6.49%+23.87%+39.32% 44.11B
-1.88%+3.25%+40.14%+53.16% 41.42B
-2.27%+16.07%+133.21%+70.51% 36.18B
Average -0.57%+6.06%+11.47%+10.11% 81.24B
Weighted average by Cap. -0.26%+6.14%+15.57%+17.51%

Financials

2024 2025
Net sales 20.73K 18.08K 17.07K 15.5K 29.04K 1.99M 29.16K 204K 78.89K 1.01M 77.87K 76.14K 3.25M 124K 108K 102K 92.83K 174K 11.91M 175K 1.22M 473K 6.06M 466K 456K 19.49M
Net income -14.86M -12.96M -12.24M -11.11M -20.82M -1.43B -20.91M -147M -56.57M -725M -55.83M -54.59M -2.33B -14.77M -12.88M -12.16M -11.04M -20.69M -1.42B -20.78M -146M -56.22M -721M -55.49M -54.26M -2.32B
Net Debt 8.11M 7.07M 6.68M 6.06M 11.36M 778M 11.4M 79.96M 30.86M 396M 30.45M 29.78M 1.27B 10.58M 9.23M 8.71M 7.91M 14.82M 1.02B 14.89M 104M 40.28M 516M 39.75M 38.87M 1.66B
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
18/09/26 $1.480 -0.67% 51,656
17/09/26 $1.490 +7.97% 31,853
16/09/26 $1.380 +0.73% 67,657
15/09/26 $1.370 0.00% 26,478
14/09/26 $1.370 -4.86% 35,782
  1. Stock Market
  2. Stocks
  3. AIMD Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!